Agilent Application Note: Analysis of Antihypertensive Drugs by HPLC

This document introduces HPLC methods for the analysis of two antihypertensive drugs


Agilent Application Note: Analysis of Antihypertensive Drugs by HPLC - cover page
Brand
Agilent
Document type
Application Note
Language
English
Pages
2
File format
PDF
File size
39 KB
Published
03 July, 2012
Updated
30 September, 2023
MD5 checksum
47CF73B8984B2CD0902FFB695BAB6B43

About this manual

The document details an HPLC method for separating two antihypertensive drugs, captopril and enalapril. The analysis utilizes gradient elution on a Zorbax SB-C18 reversed-phase column with UV detection at 204 nm.

Experimental conditions include the use of an Agilent 1100 Series HPLC system, specific mobile phases (KH2PO4 in water and acetonitrile), and a temperature of 60°C. The note highlights the performance data, including limits of detection and precision.

What's inside

  • Analysis of Antihypertensive Drugs
  • Captopril and Enalapril Separation
  • Experimental Conditions
  • HPLC Performance Data
  • Zorbax SB-C18 Column
  • Gradient Analysis
  • UV Detection

Specifications

HPLC SystemAgilent 1100 Series HPLC
Detector Wavelength204 nm
Column TypeZorbax SB-C18, 3.5 µm, 4.6 x 75 mm
Injection Volume5 µL
Column Temperature60 °C
Flow Rate1.0 mL/min

Frequently asked questions

Which drugs are analyzed in this method?

The method analyzes captopril and enalapril.

What is the limit of detection for Captopril?

The LOD for Captopril is 0.5 mg/L.

Download PDF (39 KB)

More Agilent Manuals


View all Agilent manuals →